Deka Bank Deutsche Girozentrale Adverum Biotechnologies, Inc. Transaction History

Deka Bank Deutsche Girozentrale

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$2.08 - $3.6 $67,600 - $117,000	-32,500 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$3.36 - $10.56 $33,600 - $105,600	-10,000 Reduced 23.53%	32,500 $113,000
Q1 2021 Apr 28, 2021	BUY	$9.26 - $14.36 $92,600 - $143,600	10,000 Added 30.77%	42,500 $397,000
Q4 2020 Mar 12, 2021	BUY	$9.84 - $14.26 $319,800 - $463,450	32,500 New	32,500 $380,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.